LAGUNA HILLS, Calif., Oct. 4 /PRNewswire-FirstCall/-- CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company (http://www.CalbaTech.com) concentrating on the collection and banking of adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech and pharmaceutical research markets and to academic institutions, today announced a corporate update.
LifeStem(TM), Inc., a CalbaTech wholly-owned subsidiary that has developed a unique process to harvest adult stem cells in micro quantities to be cryopreserved for future transplantation into the same client for medical purposes, will be in Atlanta, Georgia this week to train employees of a medspa that will begin selling the Stem Cell Microbank(TM) Service in its Atlanta location. Pre-marketing of the service in the "Atlanta Life" magazine has, according to the owner of the spa, resulted in significant interest by potential clients. LifeStem(TM) will be training the staff in both selling and harvesting techniques.
TherapyStem, Inc., a wholly-owned subsidiary of CalbaTech, signed an MOU with Australian-based Benitec Limited, in which TherapyStem will develop a business providing stem cell storage services for U.S. HIV patients who may use the blood-based stem cells in a possible therapy. Benitec has collaborated with City of Hope, Duarte, California, a biomedical research and treatment center, in the development of a possible HIV therapeutic. This investigational HIV therapeutic creates the possibility that re-engineered blood-based stem cells may be able to take the place of anti-retroviral medication. TherapyStem, Inc. has filed for patent protection for its process to harvest stem cells from HIV infected individuals to be cryopreserved for future transplantation.
MyStem, Inc., a developing wholly-owned subsidiary of CalbaTech, is
working to build a platform in which it will sell Li
|SOURCE CalbaTech, Inc.|
Copyright©2007 PR Newswire.
All rights reserved